Drug Shortage Report for MAR-APIXABAN
| Report ID | 222212 |
| Drug Identification Number | 02492377 |
| Brand name | MAR-APIXABAN |
| Common or Proper name | APIXABAN |
| Company Name | MARCAN PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | APIXABAN |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 60 |
| ATC code | B01AF |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-03-14 |
| Estimated end date | 2024-04-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-03-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-03-15 | English | Compare |
| v2 | 2024-03-14 | French | Compare |
| v1 | 2024-03-14 | English | Compare |
Showing 1 to 3 of 3